PharmaDispatch - BioPharmaDispatch

Comment
US proposal a 'game over' moment for Australian access

The obvious and inevitable risk of the proposal is that companies will act to innoculate their larger and more lucrative market by not launching or significantly delaying the launch of new medicines in Australia. They may even be forced to consider removing already reimbursed medicines.

Latest News How the federal government gets to 2,200 'medicines' October 17, 2019
The November PBS schedule update includes some new medicines and a large number of 'new or amended items'.
Latest News Pricing proposal will 'destroy' the industry and halve drug approvals October 17, 2019
An official analysis of a new medicine pricing plan under consideration by the US Congress suggests it could halve the number of new medicines and ultimately undermine health outcomes.
Latest News Threshold legislation sparks renewed PBS debate October 17, 2019
The major parties have used the parliamentary debate over the proposed lowering of PBS safety net thresholds to prosecute their wider arguments on the program.
Latest News Department of Health: Ask the minister's office October 16, 2019
BioPharmaDispatch asked the Department to confirm it had provided this advice, specifically that 2,200 "medicines" had been added to the PBS.
Latest News PBAC chair shares his thoughts on review October 16, 2019
PBAC chair Professor Andrew Wilson has articulated his thoughts on the pending review of the National Medicines Policy.
Latest News Chris Bowen: Government 'not really telling the truth' on PBS October 16, 2019
Shadow minister Chris Bowen accused the government of "not really telling the truth" during an address to PharmaAus19 in Canberra yesterday.
Latest News PSA confirms appointment of new CEO October 16, 2019
“We are delighted to have someone of Mark’s experience leading PSA into its next stage,” said PSA national president, Associate Professor Chris Freeman.
Hunt: We have listed more and cut listing times October 15, 2019
Health minister Greg Hunt has defended the Coalition's record on the PBS at his opening address to this morning's PharmAus19 meeting in Canberra.
Latest News Bowen: Backed review knowing it 'would probably' mean more for PBS October 15, 2019
Shadow health minister Chris Bowen will tell PharmAus in Canberra today that as shadow treasurer he agreed to a review of the National Medicines Policy knowing it "would probably recommend greater investment in the PBS."
Latest News What next for tumour agnostic therapies? October 15, 2019
The 'tumour agnostic' therapy presents a new challenge to the PBS given the nature of trials and the likelihood companies may take different approaches to the assessment process.
Are 'new items' the same as new listings? October 14, 2019
The government could count the new October listings of REVESTIVE (teduglutide), TECENTRIQ (atezolizumab), AVASTIN (bevacizumab) and RIXIMYO (rituxumab) as 24 'new or amended items' - it might be 24 new items but arguably it was four listings.

News of the Day

Latest Video

Most Read

New Stories